Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging

Completed · Early Phase 1

Conditions studied: Ischemic Heart Disease, Myocardial Infarction

In brief

Positron emission tomography (PET) scans can be used to evaluate whether parts of the heart muscle are alive but receiving inadequate blood supply. This study involves the use of two radiotracers that will measure whether heart muscle cell are alive and quantify the blood supply to the heart muscle.

Key facts

Study ID

NCT02003456

Run by

University of Michigan

People needed

30

Starts

2013-12-01

Expected to finish

2014-08-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Patients referred for clinically indicated positron emission tomography (PET) viability assessment with rubidium-82 rest perfusion imaging and 18F-fluorodeoxyglucose (FDG) metabolic imaging.

You may not qualify if…

• Need for stress perfusion imaging
• Claustrophobia which would prevent positron emission tomography (PET) imaging.
• Inability to lie flat with arms positioned next to the head for approximately 20 minutes.
• Clinical instability such as uncontrolled, potentially life threatening arrhythmias or heart failure requiring mechanical support or infusions of inotropic or vasopressor agents.
• Pregnancy

Where it is running

• University of Michigan Hospital — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.